A receptor mutation that essentially blocks estrogen's action has been identified for the first time in a female, researchers report. The 18-year-old wasn't experiencing breast development or ...
Breast cancer is the most common cancer diagnosed in U.S. women. In hormone receptor positive, HER2 negative advanced cases, ...
A new review details how ESR1 mutations, bypass signaling, and cell-cycle escape drive endocrine resistance in the most ...
Debio 0123 (zedoresertib), a selective WEE1 inhibitor, in combination with carboplatin in adult patients with platinum-resistant ovarian cancer: Expansion part of the Debio0123-101 phase 1 study. A ...
If you have estrogen receptor-positive (ER-positive) metastatic breast cancer, your doctor will most likely recommend hormone (endocrine) therapy. That's because the estrogen hormone can attach to ...
SEATTLE, May 27, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other ...
Please provide your email address to receive an email when new articles are posted on . Vepdegestrant improved PFS for patients with ER-positive, HER2-negative advanced breast cancer with an ESR1 ...
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended that Inluriyo ( imlunestrant, Eli Lilly Nederland B.V.) be given marketing ...
Veramorph LLC (VeraMorph) is a specialty pharmaceutical company utilizing its "degradable gel" oral drug delivery platform to develop a pipeline of clinically differentiated orally reformulated drug ...
Scientists at The Wistar Institute have solved a longstanding puzzle in ovarian cancer treatment: why anti-estrogen therapy often fails even when tumors express the hormone receptor that should make ...
Hormone receptor-positive (HR+)/HER2-negative breast cancer is the most common type of breast cancer. As you and your doctor decide on treatment, a key piece of the picture will be whether your breast ...
An integrated study of estrogen receptor alpha evolution across 169 mammalian species reveals how ecological traits and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results